相关实验视频
Updated: Jul 18, 2025

11:12
Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
Published on: July 16, 2014
22.5K
离线深度强化学习和非政策评估,用于1型糖尿病的个性化基础胰岛素控制
IEEE journal of biomedical and health informatics
|August 22, 2023
概括
这项研究引入了人工胰腺系统的离线深度强化学习框架,改善了1型糖尿病管理中的基础胰岛素控制,而不需要实时在线交互.
科学领域:
- 生物医学工程 生物医学工程
- 人工智能在医学中的应用
- 糖尿病 技术 技术
背景情况:
- 混合闭环系统或人工胰腺 (AP) 优化了1型糖尿病 (T1D) 的葡萄糖控制.
- 深度强化学习 (DRL) 提供了先进的基础胰岛素控制,但需要广泛的在线互动,限制了临床应用.
- 由于在线交互的要求,目前AP系统的DRL控制器在现实世界中使用是不切实际的.
研究的目的:
- 提出和评估一个离线深度强化学习 (DRL) 框架,用于人工胰腺 (AP) 系统的基础胰岛素控制.
- 为了使AP模型的开发和验证完全离线,绕过实时在线交互的需要.
- 增强1型糖尿病患者个性化的基础胰岛素控制.
主要方法:
- 开发了一个线下DRL框架,集成双延迟深确定性政策梯度 (TD3) 和行为克隆.
- 纳入政策之外的评估 (OPE) 使用合适的Q评估进行模型性能评估.
- 使用in silico数据集 (UVA/Padova T1D模拟器) 和真实临床数据集 (OhioT1DM) 验证了框架.
主要成果:
- 线下DRL算法显著增加了范围内的时间 (TIR),同时减少了成人和青少年在中范围以下的时间 (TBR) 和范围以上的时间 (TAR).
- 政策之外的评估 (OPE) 显示,临床数据集中的每个主体的政策价值显著增加.
- 通过离线DRL模型开发,证明了改善葡萄糖控制指标,包括TIR,TBR和TAR.
结论:
- 拟议的线下DRL框架为开发针对1型糖尿病的个性化基础胰岛素控制策略提供了一种可行和安全的方法.
- 离线模型开发和验证是基于DRL的AP系统在线学习的切实替代方案.
- 这种方法具有显著的潜力,可以通过先进的人工胰腺技术改善1型糖尿病的自我管理.
更多相关视频
相关概念视频
Insulin: Dosing Regimen and Adverse Effects
205
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
205
Diabetes: Management and Pharmacotherapy
310
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
310
Diabetes Mellitus: Overview and Type I Subtype
2.8K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.8K
Insulin Formulations: Types and Delivery
226
Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into...
Short-acting insulins are divided into...
226
Diabetes Mellitus: Type 2 and Gestational
2.5K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.5K
Insulin: Biosynthesis, Chemistry, and Preparation
428
The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
428

